Trabectedin in Soft Tissue Sarcomas

By Petek Bradley J.   Loggers Elizabeth T.   Pollack Seth M.   Jones Robin L.  

Marine Drugs, Vol. 13, Iss. 2, 2015-02 ,pp. : 974-983

MDPI

Access to resources Recommend Favorite

The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin

By Kasper Bernd   Schmitt Thomas   Wuchter Patrick   Dimitrakopoulou-Strauss Antonia   Ho Anthony D.   Egerer Gerlinde  

Marine Drugs, Vol. 7, Iss. 3, 2009-07 ,pp. : 331-340

MDPI

Access to resources Recommend Favorite

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)

By Kasper Bernd   Reichardt Peter   Pink Daniel   Sommer Michaela   Mathew Monika   Rauch Geraldine   Hohenberger Peter  

Marine Drugs, Vol. 13, Iss. 1, 2015-01 ,pp. : 379-388

MDPI

Access to resources Recommend Favorite

Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma

By Yang Jia-Lin   Das Gupta Romi   Goldstein David   Crowe Philip J.  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 1159-1159

MDPI

Access to resources Recommend Favorite

Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors

By Ferrel Ethan A.   Roehrig Andrew T.   Kaya Erin A.   Carlson Jonathan D.   Ling Benjamin C.   Wagner Aaron   MacKay Alexander R.   Call Jason A.   Demakas John J.   Lamoreaux Wayne T.   Fairbanks Robert K.   Cooke Barton S.   Peressini Ben   Lee Christopher M.  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 400-400

MDPI

Access to resources Recommend Favorite